Carbidopa/Levodopa
Brand name: Carbidopa-Levodopa
Rank #105 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$168.3M
Total Cost
1,361,770
Total Claims
$168.3M
Total Cost
24,022
Prescribers
$124
Cost per Claim
254,279
Beneficiaries
2,393,768
30-Day Fills
$7,008
Avg Cost/Provider
57
Avg Claims/Provider
Share of Medicare Part D Spending
0.06%
of total Medicare Part D spending
$168.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $168.3M total
Top Prescribers of Carbidopa/Levodopa
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sarah Smith | Physician Assistant | Dallas, TX | 781 | $1.3M |
| 2 | Ramsey Falconer | Neurology | Alexandria, VA | 689 | $1.3M |
| 3 | Hoai-Huong Huynh | Nurse Practitioner | La Jolla, CA | 425 | $1.1M |
| 4 | Meredith Hatcher | Physician Assistant | Georgetown, TX | 554 | $1.1M |
| 5 | Sherrie Gould | Nurse Practitioner | La Jolla, CA | 770 | $966K |
| 6 | Dean Sutherland | Neurology | Sarasota, FL | 463 | $949K |
| 7 | George Plotkin | Neurology | Tyler, TX | 786 | $908K |
| 8 | David Kreitzman | Neurology | Commack, NY | 772 | $893K |
| 9 | Irene Oh | Neurology | Carlsbad, CA | 654 | $687K |
| 10 | Rita Ceponiene | Neurology | San Diego, CA | 179 | $666K |
| 11 | Mark Ledoux | Emergency Medicine | Memphis, TN | 358 | $612K |
| 12 | Sotirios Parashos | Neurology | St Louis Park, MN | 309 | $597K |
| 13 | Rasheda El-Nazer | Neurology | Richardson, TX | 378 | $579K |
| 14 | Elizabeth Peckham | Neurology | Round Rock, TX | 445 | $560K |
| 15 | Lin Zhang | Neurology | Sacramento, CA | 286 | $546K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 102 | Potassium Chloride (Klor-Con M20) | $172.6M | 6,137,143 |
| 103 | Darunavir/Cob/Emtri/Tenof Alaf (Symtuza) | $172.5M | 34,812 |
| 104 | Tamsulosin Hcl (Tamsulosin Hcl) | $168.5M | 8,367,036 |
| 105 | Carbidopa/Levodopa (Carbidopa-Levodopa) | $168.3M | 1,361,770 |
| 106 | Duloxetine Hcl (Duloxetine Hcl) | $167.7M | 5,106,690 |
| 107 | Sucroferric Oxyhydroxide (Velphoro) | $166.8M | 54,837 |
| 108 | Lifitegrast (Xiidra) | $166.6M | 149,269 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology